test

Sarah B Goldberg MD, MPH

Assistant Professor of Medicine (Medical Oncology)

Clinical Interests

Lung Cancer; Thoracic Oncology; Personalized Medicine


Board Certifications

Hematology (Internal Medicine), Board Eligible
2009
Internal Medicine, Board Certified
2012
Medical Oncology, Board Certified

Clinical Trials

ConditionsStudy Title
LungLung Cancer Mutation Consortium Protocol
LungA Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects With Advanced Non-Small Cell Lung Cancer
LungPhase 1b/2, Multicenter, Open-label Study of Carfilzomib, Carboplatin, and Etoposide in Subjects with Previously Untreated Extensive-stage Small-cell Lung Cancer
Bladder, Breast - Female, Lung, Pancreas, and StomachA Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
LungA Phase 1b/2 Study of OMP-59R5 in Combination with Etoposide and Platinum Therapy in Subjects with Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE: Phase 1b/2 INvestigation of anti-Notch Antibody Therapy with Cisplatin and Etoposide in Small Cell Lung Carcinoma Safety and Efficacy)

More Clinical Trials...

Edit Profile